Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Core page now includes a government funding/operating-status notice and a new version v3.2.0, replacing the older v3.0.2.
    Difference
    2%
    Check dated 2025-10-01T14:26:50.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    - Updated version label from v3.0.1 to v3.0.2. - Removed the old revision tag (v3.0.1) and a Back to Top cue. - Overall impact appears to be a branding/version update with minimal to no change in core content or user-facing features.
    Difference
    0.1%
    Check dated 2025-09-17T04:58:54.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Version bumped from v3.0.0 to v3.0.1 and a Back to Top control was added; this is a minor patch and UX enhancement with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-09T21:32:55.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of numerous principal investigator contact details and the addition of new dates for updates. The revision number has also been updated.
    Difference
    19%
    Check dated 2025-08-12T05:21:54.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page has updated its contact information for two principal investigators, Clay M. Hoerig and Rebecca J. Deyell, and has revised the last update date and version number.
    Difference
    0.6%
    Check dated 2025-08-05T01:42:32.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    The page has been updated to reflect new contact information for the Principal Investigator, Elizabeth A. Raetz, and the addition of the HHS Vulnerability Disclosure. Additionally, the last update date has changed to July 28, 2025, and the revision number has been updated to v2.16.8.
    Difference
    1%
    Check dated 2025-07-29T00:12:23.000Z thumbnail image

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.